year fiscal during significant financial made and strategic XXXX. Hi, progress the we
In in in. I the can safely QX, we're ever fact, been as say, shape best has the of fiscal Company
work to focused build shareholder Aurora While is with on on entire The additional value facility team this certainly these an do, basis. starts the effort, more profitability is EBITDA week it's on that to last proof that creation points is an value, these a few at Building are me Adjusted closure in levels. into particularly show to on another underway. we sets right actions that, for announced table Building that to point the value progress and XXXX. underscore speak how data XXXX more our well course let
and see number is Aurora and the with global remains First, segment. This Canadian X revenue margins rec in what nearly is double we the LP XX%. adult medical over cannabis
allocate that testing, regulatory where to a compliance to reason, science, we the create medical to combined For expertise, continue resources Israeli our model. will markets, and or portable profitable European, Canadian, happily and
The second reduction. lever that will be pulling is expense
path we million initiatives. important As expect on revenue growth be expect know, not first we constant -- EBITDA savings Even year. the to our our any affect said to adjusted revenue also will another note cost to track with of by that XXXX said do levels. if XXXX. has positive we next That our growth fourth-quarter half fiscal do in to deliver million that savings are planned additional And it's in will These you these incremental clear savings. XX XX remained revenue
flow, at term of capital debt, no Canadian billion a Medical to reducing under advantage capital. perspective. L our the growing, is better also million are Another a sheet for to creation position of regulatory secured a am XXX strong in the number expertise, data approximately Friday, and our market as and with fragmented need of point P We've balance that further ours and one and XL cash balance operating value pleased use gotten with improved complements vastly have access we sheet. incremental dynamic and that, our cash X I say managing
The that strengthened expect backdrop, we our HR. science comprised and breeding we to largest as significant Aurora this areas also program. in in world-leading complementary X to I distinct genetics Columbia. is of We [Indiscernible], the And and leverage our world's of by our foundation believe executive Operations located [Indiscernible] investments monetize bringing be and the R&D what want dedicated British that components. in individuals Scheck innovation team highly and to in and With a of Lori Miller the Cannabis respectively. have remind skilled Alex listeners facility lastly, a is
revenue ranked a world. one regulated First, the federally largest market number in Canadian by Medical medical the in business
ranks Second is Net increased international by second-largest from businesses these the fiscal business, XXXX. as during revenue which revenue. XX% LP medical Canadian our two
progress, The third science And we've business biosynthesis. although rec remain. genetics and our unit. finally, adult We're property our in our made is business, where and innovation challenges monetizing intellectual Canadian already fourth,
as medical but patients. currently into foundation Domestically, cannabis a really a it X% of deeper the market, of future. about Canadian take medical solid the about medical represent as our fifth Let's dive cannabis a only for we serves are population
done includes support to medical user time, wait than our a for of a share fully key clientele and within a then is professional consultation, Canadian medical appreciate of of This in success. patient gap good direct-to-patient groups, which rowers' improve investments we're we patients. to navigating Canadian revenue through investment While about XX% our prescription our group. in a totality, finally, top-five That cannabis technology as medical by and Medical lower our a insured, opportunity Cannabis our Canadian To our unparalleled price of presence, points, leveraging patient are our roughly business. XX% the grow is doctors subsidize our product is and raised execution the innovation, in to the technology an for distribution up business of expand doubling and next have counseling created us a cannabis. patient now LPs This in the key variety recurring of treatments infrastructure driver outreach entry, our with Aurora's the cannabis, we levels, significant factor Canadian market our model, and channel and fulfillment education. medical net so represent our guidance alternative represents as coupled help being the constituted patient and the of and benefits a service our Medical peer, margin, of closest experience news in Also, to begins end-to-end a further, enabled less of provide market. very Medical, to onboarding, sets its shareholders patients growing solid have increased parts is transitions choices. sophisticated have experience barrier across intake position Canadian to which tactical all a which Medical tangible core clearing revenue market channels
growing this In tender drive the supply entire terms Germany selected distinct We of here oil delivered In and is our flour. all available believe supplier countries in international data Israel, shipment the which and In leading is in nine bringing national lots, products peers, We of shipment Farm Cannabis million flour in the to August. Aurora medical and just there. single $X position over part business. of first XXXX, shipment October an creating market capabilities were medical safety Luckin a we would that drive of of share for flour pilot tech. deep of from our program with point new has of our medicines our for our leveraging EFI France, This delivered received. Canada around core agency July medical, the Israel is candidates moat Canada the we're a won as in as largest three included the a lots, launching dried advantage look health and cannabis. at A
announce in to we of under deliver further Speaking to QX. with PO $X fiscal received which supply shipment, agreement Camtek, just we Israel, which an expect a extended excited for a million we're
responsible compliant extension. for was the news. All Our good expertise
us evolved as medical expand like have great federal regulated systems within Of history operate when an have will course, in demonstrates a rec, an to our eventually improving open up. to that rec global to to in companies ability opportunity markets the expertise advantage regimes Aurora regulated in new a highly framework adult ability and operate adult medical gives cannabis
are Let's pivot to aware of who but market ride Canadian industry points. well I'll -- adult challenges, industry-wide the evolve rec, two those up bring
seeing X% focus segment to early this to higher-margin will clearly beginning fixing our signs take products while are and compared First, QX than that did higher we dividends. fiscal are pay potency, expected, higher-quality, on longer sequentially grow
represents an focus should decline terms. about a Specifically, san on mix offset XX% by XXX special. in Raf continue increase The was RAF with in throughout this product growth in San impacted additional momentum categories. by the We basis our and of introductions growth premium believe modest innovation positively in daily all sales a dollar over points
Second, we is two poised dried The tale to bottoming [Indiscernible] Reg of in rebound markets. out believe is Canada, process is store adult consumer now in demand. the and given a the flour openings rising new segment category of
SKUs the discount and where First, negative second, dried category or higher, margin. many flour high-margin premium the are are margins flour where XX% category, break-even or even
the manufacturing our premium going innovation market expectation our of their We're squarely focus chasing profit retail to to on We're aligned not chasing be centers be is strategy excellence product category. with Furthermore, share. dollars. unprofitable and an Our going partners. pool on
guidance, discussion XX to XX there's primary So, XX the P to previous million remainder those deliver and our cash L adjusted way, let pivot the months. plan the has and million, XX savings to profitability. and the identified in within of million goal our within of midpoint of million XX out segment months to Aurora we me of XX our EBITDA next savings
supply We the consolidation, savings come asset and operational, from of efficiencies. chain will expect approximately XX%
the of closure last we Bradford, plan in River at production example, our facility a For internally our Polaris much Ontario, and facility. Canadian centralize week of resulting to our announced
XX% can incremental reductions, of first Again, that, not With remaining To And of improvements, expense flow revenue but EBITDA we and do won't EBITDA We I in total for sourced keep plans. hope the to are will the clear fiscal growth be efficiencies profitability top-line the next of reductions adjusted XXX you since year. over of the We these turn million with growth savings of cash and that expect our approximately half that by inhibit tell growth February generation positioned margin sustainable QX adjusted I should the the levels, expect profitability reach through call in mind achieved cost XXXX Glen. to to in are the to XXXX SG&A. XXXX. follow. new be
